Role of Long Noncoding RNAs in Parkinson’s Disease: Putative Biomarkers and Therapeutic Targets
Parkinson’s disease (PD) is a neurodegenerative disease characterized by bradykinesia, rigidity, and tremor. Age is the main risk factor. Long noncoding RNAs (lncRNAs) are novel RNA molecules of more than 200 nucleotides in length. They may be involved in the regulation of many pathological processe...
Saved in:
| Main Authors: | Qiankun Lv, Ziyu Wang, Zhen Zhong, Wei Huang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-01-01
|
| Series: | Parkinson's Disease |
| Online Access: | http://dx.doi.org/10.1155/2020/5374307 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exosomal Long NonCoding Rnas as Cancer Biomarkers and Therapeutic Targets
by: O. A. Beylerli, et al.
Published: (2020-01-01) -
Long noncoding RNAs in familial hypercholesterolemia: biomarkers, therapeutics, and AI in precision medicine
by: Hussam Daghistani, et al.
Published: (2025-05-01) -
Noncoding RNAs in Diabetic Nephropathy: Pathogenesis, Biomarkers, and Therapy
by: Jiarong Lv, et al.
Published: (2020-01-01) -
Identification of Differentially Expressed Genes and Long Noncoding RNAs Associated with Parkinson’s Disease
by: Lu-Mei Chi, et al.
Published: (2019-01-01) -
Noncoding RNA landscape and their emerging roles as biomarkers and therapeutic targets in meningioma
by: Ritanksha Joshi, et al.
Published: (2024-03-01)